PLoS Pathogens (Apr 2020)
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
- Luca Schifanella,
- Susan W Barnett,
- Massimiliano Bissa,
- Veronica Galli,
- Melvin N Doster,
- Monica Vaccari,
- Georgia D Tomaras,
- Xiaoying Shen,
- Sanjay Phogat,
- Ranajit Pal,
- David C Montefiori,
- Celia C LaBranche,
- Mangala Rao,
- Hung V Trinh,
- Robyn Washington-Parks,
- Namal P M Liyanage,
- Giacomo Gorini,
- Dallas R Brown,
- Frank Liang,
- Karin Loré,
- David J Venzon,
- William Magnanelli,
- Michelle Metrinko,
- Josh Kramer,
- Matthew Breed,
- Galit Alter,
- Ruth M Ruprecht,
- Genoveffa Franchini
Affiliations
- Luca Schifanella
- Susan W Barnett
- Massimiliano Bissa
- Veronica Galli
- Melvin N Doster
- Monica Vaccari
- Georgia D Tomaras
- Xiaoying Shen
- Sanjay Phogat
- Ranajit Pal
- David C Montefiori
- Celia C LaBranche
- Mangala Rao
- Hung V Trinh
- Robyn Washington-Parks
- Namal P M Liyanage
- Giacomo Gorini
- Dallas R Brown
- Frank Liang
- Karin Loré
- David J Venzon
- William Magnanelli
- Michelle Metrinko
- Josh Kramer
- Matthew Breed
- Galit Alter
- Ruth M Ruprecht
- Genoveffa Franchini
- DOI
- https://doi.org/10.1371/journal.ppat.1008531
- Journal volume & issue
-
Vol. 16,
no. 4
p. e1008531
Abstract
[This corrects the article DOI: 10.1371/journal.ppat.1008121.].
